HMOX1 and Hepatic fibrosis: The study suggests that hiHep-EVs present a promising therapeutic role for liver fibrosis, underscoring their ability to modulate Nrf2 and HO-1 for potent anti-fibrotic effects (Liu W. et al., 2023).